Belviq was approved by the FDA in 2012 as a chronic weight-management medication for adults with obesity or weight-related medical conditions. It functioned as a serotonin 2C receptor agonist, increasing feelings of fullness.
It was voluntarily withdrawn from the U.S. market in February 2020 at the request of the FDA due to safety clinical trials showing an increased occurrence of cancer. buy belviq online usa
The FDA formally withdrew the drug's approval on September 17, 2020, and subsequently removed it from the Orange Book in 2021, making any sale or distribution into interstate commerce illegal. Clinical Data: The CAMELLIA-TIMI 61 Trial Belviq was approved by the FDA in 2012
Below is a detailed overview of the drug's history, the research leading to its removal, and current safe alternatives. The Rise and Fall of Belviq (Lorcaserin) market in February 2020 at the request of
Copyright © 2025 Telugudesk